BLAIR JAMES C

Related Filers (57)

Ownership (385)

4
Friday, 6/11/2021
Clovis Oncology, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/5/2020
Clovis Oncology, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 8/20/2019
Clovis Oncology, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 8/8/2019
OBALON THERAPEUTICS INC: Statement of changes in beneficial ownership of securities
4
Monday, 6/10/2019
Clovis Oncology, Inc.: Statement of changes in beneficial ownership of securities
3
Monday, 5/13/2019
Alliqua BioMedical, Inc.: Initial statement of beneficial ownership of securities
3
Monday, 5/13/2019
Alliqua BioMedical, Inc.: Initial statement of beneficial ownership of securities
4
Friday, 5/10/2019
aTYR PHARMA INC: Statement of changes in beneficial ownership of securities
4
Monday, 3/18/2019
Clovis Oncology, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/5/2019
Clovis Oncology, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 10/15/2018
Clovis Oncology, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 8/27/2018
OBALON THERAPEUTICS INC: Statement of changes in beneficial ownership of securities
4
Monday, 8/27/2018
BioNano Genomics, Inc: Statement of changes in beneficial ownership of securities
4
Monday, 8/27/2018
BioNano Genomics, Inc: Statement of changes in beneficial ownership of securities
3
Tuesday, 8/21/2018
BioNano Genomics, Inc: Initial statement of beneficial ownership of securities
3
Tuesday, 8/21/2018
BioNano Genomics, Inc: Initial statement of beneficial ownership of securities
3
Tuesday, 8/21/2018
BioNano Genomics, Inc: Initial statement of beneficial ownership of securities
4
Wednesday, 5/23/2018
Clovis Oncology, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 5/17/2018
aTYR PHARMA INC: Statement of changes in beneficial ownership of securities
4
Wednesday, 12/20/2017
Dicerna Pharmaceuticals Inc: Statement of changes in beneficial ownership of securities
4
Wednesday, 12/20/2017
Dicerna Pharmaceuticals Inc: Statement of changes in beneficial ownership of securities
4
Wednesday, 12/13/2017
Ocera Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 12/13/2017
Ocera Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 12/13/2017
Ocera Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 12/13/2017
Ocera Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 12/13/2017
Ocera Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 8/18/2017
Clovis Oncology, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 8/8/2017
Clovis Oncology, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/27/2017
Clovis Oncology, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 6/12/2017
Clovis Oncology, Inc.: Statement of changes in beneficial ownership of securities
4/A
Tuesday, 5/23/2017
Clovis Oncology, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 5/11/2017
aTYR PHARMA INC: Statement of changes in beneficial ownership of securities
4
Wednesday, 4/12/2017
Dicerna Pharmaceuticals Inc: Statement of changes in beneficial ownership of securities
4
Wednesday, 4/12/2017
Dicerna Pharmaceuticals Inc: Statement of changes in beneficial ownership of securities
4
Friday, 11/4/2016
Tobira Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 11/3/2016
Tobira Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 11/3/2016
Tobira Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 11/3/2016
Tobira Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 11/3/2016
Tobira Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 10/14/2016
OBALON THERAPEUTICS INC: Statement of changes in beneficial ownership of securities
4
Friday, 10/14/2016
OBALON THERAPEUTICS INC: Statement of changes in beneficial ownership of securities
3
Wednesday, 10/5/2016
OBALON THERAPEUTICS INC: Initial statement of beneficial ownership of securities
3
Wednesday, 10/5/2016
OBALON THERAPEUTICS INC: Initial statement of beneficial ownership of securities
4
Tuesday, 9/13/2016
CoLucid Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/3/2016
CoLucid Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/3/2016
CoLucid Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 6/13/2016
Clovis Oncology, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 5/27/2016
Evoke Pharma Inc: Statement of changes in beneficial ownership of securities
4
Friday, 5/27/2016
Evoke Pharma Inc: Statement of changes in beneficial ownership of securities
4
Thursday, 5/26/2016
aTYR PHARMA INC: Statement of changes in beneficial ownership of securities
4
Monday, 5/2/2016
CoLucid Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 5/2/2016
CoLucid Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 4/27/2016
Evoke Pharma Inc: Statement of changes in beneficial ownership of securities
4
Wednesday, 4/27/2016
Evoke Pharma Inc: Statement of changes in beneficial ownership of securities
4
Thursday, 4/21/2016
Evoke Pharma Inc: Statement of changes in beneficial ownership of securities
4
Thursday, 4/21/2016
Evoke Pharma Inc: Statement of changes in beneficial ownership of securities
4
Wednesday, 4/13/2016
Evoke Pharma Inc: Statement of changes in beneficial ownership of securities
4
Wednesday, 4/13/2016
Evoke Pharma Inc: Statement of changes in beneficial ownership of securities
4
Friday, 4/8/2016
Evoke Pharma Inc: Statement of changes in beneficial ownership of securities
4
Friday, 4/8/2016
Evoke Pharma Inc: Statement of changes in beneficial ownership of securities
4
Tuesday, 3/8/2016
Syndax Pharmaceuticals Inc: Statement of changes in beneficial ownership of securities
4
Tuesday, 3/8/2016
Syndax Pharmaceuticals Inc: Statement of changes in beneficial ownership of securities
4
Tuesday, 3/8/2016
Syndax Pharmaceuticals Inc: Statement of changes in beneficial ownership of securities
4
Tuesday, 3/8/2016
Syndax Pharmaceuticals Inc: Statement of changes in beneficial ownership of securities
3
Wednesday, 3/2/2016
Syndax Pharmaceuticals Inc: Initial statement of beneficial ownership of securities
3
Wednesday, 3/2/2016
Syndax Pharmaceuticals Inc: Initial statement of beneficial ownership of securities
3
Wednesday, 3/2/2016
Syndax Pharmaceuticals Inc: Initial statement of beneficial ownership of securities
3
Wednesday, 3/2/2016
Syndax Pharmaceuticals Inc: Initial statement of beneficial ownership of securities
3
Wednesday, 3/2/2016
Syndax Pharmaceuticals Inc: Initial statement of beneficial ownership of securities
4
Friday, 1/29/2016
aTYR PHARMA INC: Statement of changes in beneficial ownership of securities
4
Thursday, 9/24/2015
Clovis Oncology, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 8/20/2015
Evoke Pharma Inc: Statement of changes in beneficial ownership of securities
4
Thursday, 8/20/2015
Evoke Pharma Inc: Statement of changes in beneficial ownership of securities
4
Friday, 7/17/2015
Clovis Oncology, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 7/10/2015
aTYR PHARMA INC: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/1/2015
GLAUKOS Corp: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/1/2015
GLAUKOS Corp: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/1/2015
GLAUKOS Corp: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/1/2015
GLAUKOS Corp: Statement of changes in beneficial ownership of securities
3
Wednesday, 6/24/2015
GLAUKOS Corp: Initial statement of beneficial ownership of securities
3
Wednesday, 6/24/2015
GLAUKOS Corp: Initial statement of beneficial ownership of securities
3
Wednesday, 6/24/2015
GLAUKOS Corp: Initial statement of beneficial ownership of securities
3
Wednesday, 6/24/2015
GLAUKOS Corp: Initial statement of beneficial ownership of securities
3
Wednesday, 6/24/2015
GLAUKOS Corp: Initial statement of beneficial ownership of securities
4
Monday, 6/15/2015
Clovis Oncology, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/12/2015
aTYR PHARMA INC: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/12/2015
aTYR PHARMA INC: Statement of changes in beneficial ownership of securities
4
Monday, 5/11/2015
CoLucid Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 5/11/2015
CoLucid Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/6/2015
Regado Biosciences Inc: Statement of changes in beneficial ownership of securities
3
Wednesday, 5/6/2015
aTYR PHARMA INC: Initial statement of beneficial ownership of securities
4
Wednesday, 5/6/2015
Tibira Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 5/6/2015
Regado Biosciences Inc: Initial statement of beneficial ownership of securities
3
Wednesday, 5/6/2015
aTYR PHARMA INC: Initial statement of beneficial ownership of securities
3
Wednesday, 5/6/2015
Tibira Therapeutics, Inc.: Initial statement of beneficial ownership of securities
3
Wednesday, 5/6/2015
aTYR PHARMA INC: Initial statement of beneficial ownership of securities
3
Tuesday, 5/5/2015
CoLucid Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
3
Tuesday, 5/5/2015
CoLucid Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 4/16/2015
Evoke Pharma Inc: Statement of changes in beneficial ownership of securities
4
Thursday, 4/16/2015
Evoke Pharma Inc: Statement of changes in beneficial ownership of securities
Show More